| 18.66 -0.02 (-0.11%) | 04-29 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.38 |
1-year : | 24.06 |
| Resists | First : | 19.16 |
Second : | 20.6 |
| Pivot price | 19.37 |
|||
| Supports | First : | 16.84 |
Second : | 14.01 |
| MAs | MA(5) : | 19.15 |
MA(20) : | 19.31  |
| MA(100) : | 22.24 |
MA(250) : | 22.05 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 31.3 |
D(3) : | 37.4 |
| RSI | RSI(14): 41.7 |
|||
| 52-week | High : | 30.27 | Low : | 15.53 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MIR ] has closed below the lower bollinger band by 1.8%. Bollinger Bands are 60.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 19.04 - 19.15 | 19.15 - 19.24 |
| Low: | 16.59 - 16.73 | 16.73 - 16.83 |
| Close: | 18.46 - 18.68 | 18.68 - 18.85 |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Wed, 29 Apr 2026
Mirion Technologies, Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:MIR) 2026-04-29 - Seeking Alpha
Wed, 29 Apr 2026
[10-Q] Mirion Technologies, Inc. Quarterly Earnings Report - Stock Titan
Wed, 29 Apr 2026
Vanguard Portfolio Management (NYSE: MIR) discloses 18.12M-share stake - Stock Titan
Wed, 29 Apr 2026
Mirion Technologies (NYSE:MIR) Shares Down 8.6% - Time to Sell? - MarketBeat
Wed, 29 Apr 2026
Zacks.com featured highlights include Mirion Technologies, Intuit and ANI Pharmaceuticals - Yahoo Finance
Wed, 29 Apr 2026
Mirion Technologies (MIR) Q1 earnings: Taking a look at key metrics versus estimates - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Industrials
|
|
|
Industry:
Industrial - Machinery
|
|
| Shares Out | 244 (M) |
| Shares Float | 227 (M) |
| Held by Insiders | 3.5 (%) |
| Held by Institutions | 109.7 (%) |
| Shares Short | 23,600 (K) |
| Shares Short P.Month | 20,430 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.63 |
| Profit Margin | 3.1 % |
| Operating Margin | 14.1 % |
| Return on Assets (ttm) | 1.3 % |
| Return on Equity (ttm) | 1.7 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 1.79 |
| Sales Per Share | 3.78 |
| EBITDA (p.s.) | 0.83 |
| Qtrly Earnings Growth | 2.4 % |
| Operating Cash Flow | 143 (M) |
| Levered Free Cash Flow | 126 (M) |
| PE Ratio | 169.63 |
| PEG Ratio | 0 |
| Price to Book value | 2.44 |
| Price to Sales | 4.92 |
| Price to Cash Flow | 31.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|